Advanced Cancer Patients in ‘26MELBOURNE, Australia, May 20, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on ...
Kira Andersen, a widowed mother, is transforming her loss into advocacy, raising over $2 million for pancreatic cancer ...
Continuity Biosciences started a first-in-human clinical trial of its precision drug delivery platform for pancreatic cancer, ...
Scientists long ago identified their target: a smooth-surfaced protein inside cells, called KRAS, that is altered in certain ...
Researchers have discovered that different dietary fats may have dramatically different effects on pancreatic cancer, with ...
Techno-Science.net on MSN
Pancreatic cancer: an antibody proves effective
Affecting a growing number of patients, pancreatic cancer remains one of the most aggressive due to the ability of cancer ...
Catching pancreatic cancer early can increase the five-year survival rate from 15% to 80%. Patients with pancreatic cysts, ...
Darren Raddysh walked the halls of Moffitt Cancer Center in Tampa on Thursday, making sure to stop every few feet to interact ...
Orally taken medicine, being studied specifically for metastatic pancreatic cancers, targets a cell protein that has lost the ...
Earlier in May 2026, Revolution Medicines reported that its RAS(ON) inhibitor daraxonrasib delivered what it called unprecedented overall survival benefit in the pivotal Phase 3 RASolute 302 trial for ...
Researchers have uncovered an unexpected weakness in pancreatic cancer involving damaged mitochondria and a powerful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results